Digitalization of Banks for regulatory and licensing regime for India

Enregistré dans:

Détails bibliographiques
Auteur principal:	SHAH,MEET ACHAL
Format:	Thèse Livre
Langue:	anglais
Publié:	Mumbai NMIMS Mumbai 2022
Sujets:	Digitalization of Banks for regulatory and licensing regime
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

BASICS OF LICENSING AND LICENSING AGREEMENT
par: VORA RISHABH
Publié: (1218)

An Analysis on Cross Border Insolvency Regime in India & Abroad.
par: MAHESHWARI, KESHAV
Publié: (2014)

Parallel Importation of Works Protected under the Copyright Regime.
par: SHANGHAVI, AAKANKSHA
Publié: (2014)

Music Licensing and Payment of Royalties in the Digital Music Marketplace
par: Saraswat, Anuja
Publié: (2022)

Legal and Regulatory Aspects of Banking
par: Zacharias, K D; Ravindranath, C P; Kulkarni, P R; Gopalakris
Publié: (2008)

Legal and Regulatory Aspects of Banking
par: Zacharias, K D; Ravindranath, C P; Kulkarni, P R; Gopalakris
Publié: (2008)

Legal and Regulatory Aspects of Banking
par: IIBF
Publié: (2012)

An Analysis Of The Insolvency Regime Governing MSMEs
par: Rao,Ketaki
Publié: (2024)

Global IPR Regime and Broadcasting Rights Implications for India.
par: TULSHIAN, RIDDHI
Publié: (2014)

NBFCs: Regulatory framework in India
par: GUPTA,RHEA MANGAL
Publié: (2022)

"Part I - Regulatory Framework for Coronary Stents in Regulated and Semi- Regulated Countries. Part II - Understanding Regulatory Submissions: Ensuring Global Regulatory Compliance"
par: Tyagi Somya

"Part I - Analysis of Regulatory framework for Nanopharmaceuticals in the US, EU and India. Part II - Regulatory Affairs and Dossier Management at Cipla Ltd"
par: Patel Aiman

"Part I - Regulatory Considerations for Biologics Approval Processes in USA, India and EU Part II - Exploring Regulatory Affairs and Global Submissions "
par: Pawar Srushti

"Part I Regulatory Pathway And Formulation Strategy For 505(B)(2) Filing Of Oral Dispersible Strips In Anti-Epileptic Therapy Part II Navigating the Regulatory Compliance at Glaxosmith Kline Pharmaceuticals Limited for General Medicine Products Concerning Licenses and Best Practices"
par: Nair Keerthi

Part I - Regulatory Framework for Development of Paediatric Formulations Part II - Exploring Regulatory Submissions in Emerging Market
par: Dand Chandni

FDA REGULATORY AFFAIRS
par: MANTUS DAVID
Publié: (2021)

Pharmaceutical Regulatory Process,
par: Berry I.R
Publié: (2025)

Drug Regulatory Affairs
par: Itkar, Sachin
Publié: (2022)

Drug Regulatory Affairs
par: Singh
Publié: (2023)

Drug Regulatory Affairs
par: Gajendra
Publié: (2023)

"Part I Regulatory Policy Framework for Entrepreneurship with Pharmaceutical Avenues Part II Hands-On Experience at Regulatory Affairs Department of Cipla"
par: Vasmatkar Mahesh

Law of Easements and Licenses
par: Narayana, P. S.
Publié: (2020)

Regulation and Regulatory Process in India
par: Kumar, Manoj
Publié: (2019)

Drug Regulatory Affairs (PB)
par: Bigoniya
Publié: (2019)

Part I Real World Evidence for Regulatory Decision Making: Indian Framework Part II Navigating the USFDA Regulatory Landscape: Insights from Theory to Application
par: Gupta Adarsh

"Part I - Regulatory Considerations of Nitrosamines: Exploring Mutagenic and Impurities and Genotoxicity in Pharmaceuticals Part II - Navigating Regulatory Frameworks : A practical Approach To Global Compliance"
par: Gharat Sejal

Automated Document Summarizer for Bank Regulatory Documents
par: Malkar, Raj Narsinha
Publié: (2024)

"Part I Nisin-Silver Nanoconjugate in Polymeric Microneedles for Antimicrobial Action and Regulatory Aspects of Microneedles in India, USA and Europe Part II Navigating USFDA and CDSCO Regulatory Requirements and Hadling the Documentation Approaches"
par: Domb Dnyaneshwari

"Part I Comparison of Regulatory Considerations for Repurposed Drugs in US, EU, & India Part II Optimizing Regulatory Processes Enhancing Product Life Cycle Management from Initial Filimg to Post-Approval"
par: Bajaj Aanchal

"Part I - Regulatory Framework and Market Dynamics of Nutraceuticals in Major International Markets Part II - Developing Dossier and Regulatory Submission Strategies for Pharmaceutical Market Authorization in the European Union."
par: Bose Anushree

"Part I - Regulatory Perspective and Strategies to Strength and Speed Ip Commercialization Process Part II - Dossier Preparation and Regulatory Compilance in ROW: A Pratical Approach in Ajanta Pharma"
par: Dwivedi Priyam

"A Textbook of Pharmaceutical Regulatory Science"
par: Mrs. Mitesh P. Sonawane
Publié: (2022)

Unravelling The Challenges Encountered In The Cross-Border Merger Regime-A Comprehensive Analysis
par: Talekar,Vaishnavi
Publié: (2024)

"Part I - Regulatory Framework and Innovations using 505(b)(2) Pathway in Drug Development and Approval Part II - Internship at Bliss GVS Pharma in Regulatory Affairs Department- US Market"
par: Patel Astha

"Part I - Eurasian Economic Union: Analyzing Drug Registration Pathways, Dossier Requirements and Comparison with European Union's Regulatory Frameworks Part II - Implementation of Regulatory Practices for Pharmaceutical Submission in the European Union"
par: CP Keerthana

"Part I - Regulatory Compliance Leveraging Artificial Intelligence - A comprehensive Study of Opportunities and Challenges Part II - From Analytical Profiling to Regulatory Affairs - Stability, Assessment, Forced Degradation and RA Submissions for Emerging Markets "
par: Mulla Sahil

"Part I - Regulatory Aspects for Zygomatic Implants as Medical Devices in India Part II - Internship at Meril Life Sciences Pvt. Ltd & IPCA Laboratories Ltd"
par: Mistry Yukta

"Part I Regulatory Analysis and Comparison of Medical Device Recall In India, US and Europe: Understanding Causes and Consequences. Part II Dossier Preparation and Submission for US Market in Sun Pharmaceutical Industries"
par: Bodke Samruddhi

Part I Regulatory Considerations and Comparison of Drug Product Recall For Nitrosamine Impurity In India, USA And Europe Part II Navigating Regulatory Framework: A Strategic Approach in Industry"
par: Mutalik Rucha

"Part I Exploring The Regulatory Dynamics Of Artificial Intelligence (AI) and Machine Learning(ML) Based Smart Devices Part II Navigating Though the Reglatory Compliances at Glaxosmithkline Pharmaceuticals Limited for Clinical Trials in India"
par: Mourya Aman